Pharmaceuticals

Venture builder NeoSci Ventures raises S$70 million for inaugural biotech fund

2026-11-03T01:00:00.000Z
Malaysia’s largest retail pharmacy chain has launched an IPO prospectus.

Malaysia’s Big Caring eyes Singapore expansion with YMS buyout ahead of IPO

2026-10-29T11:56:52.000Z
Roland Ong, founder of Nanyang Biologics, believes the company’s listing rides a wave of investor interest that has returned to the biotech industry, in part due to the rise of AI.

Nasdaq listing awaits Singapore’s US$1.5 billion AI drug-discovery biotech Nanyang Biologics

2026-10-14T07:00:00.000Z
DHL will provide companies with dedicated logistics support and facilitate knowledge-sharing within the Life Science Incubator community.

DHL partners local life-sciences incubator to provide cold chain logistics for biotech startups

2026-09-04T10:40:36.000Z
Moderna’s stock has been on a tear this year, gaining 114% even before the melanoma trial results. 

Moderna’s 177% surge burns shorts in ‘painful’ US$5.5 billion loss

2026-08-20T09:58:23.000Z
The potential deal comes about a dozen years after AstraZeneca fended off a takeover attempt by rival Pfizer. 

AstraZeneca held talks with Bristol Myers Squibb on US$400 billion megadeal: source

2026-08-03T07:12:36.000Z
The levy would then double a year later, to 200%, in August 2029.

Trump sets 100% tariff on generic drugs with two-year delay

2026-07-22T02:23:45.000Z
For the Republic, fostering robust and competitive innovation within the healthcare industry is increasingly becoming a national priority as its population ages.

Singapore bets on AI in healthcare, but success will depend on commercial sustainability

2026-07-21T08:43:55.000Z
Jiangsu Hengrui Pharmaceuticals’ office in Shanghai, China, June 11, 2026.

Chinese drugmakers with big ambitions struggle to recruit staff for global expansion

2026-07-16T03:03:08.000Z
AstraZeneca will have the option to obtain exclusive rights to develop, manufacture and commercialise one preclinical small nucleic acid drug candidate globally.

AstraZeneca signs CSPC China deal for experimental kidney disease drugs

2026-07-02T13:24:16.000Z